Skip to main content
. 2019 Aug 22;34(1):245–256. doi: 10.1038/s41375-019-0519-4

Fig. 7.

Fig. 7

Anti-CD138 enhances sensitivity to Bortezomib treatment. a Schematic of experimental design and treatment conditions. b Comparison of tumor burden in tibia, n = 5 mice per condition. Mann–Whitney t test analysis conducted. Errors reflect SD